HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Safety Woes Make Country Of Origin Labeling “Foregone Conclusion” – Execs

This article was originally published in The Tan Sheet

Executive Summary

Supplement firms should not underestimate the potential for consumers' concerns about the safety of raw materials imported from China to affect their sales, industry executives said Oct. 6 at the Council for Responsible Nutrition's annual conference

You may also be interested in...

People In Brief

FDA appoints global, IT heads: The agency has chosen Lou Valdez as associate commissioner for international programs and Lori Davis as chief information officer. Valdez will lead the agency's further international expansion, with office openings planned for India, Latin America and the Middle East, FDA says Jan. 12. Melinda Plaisier stepped down as associate commissioner for international programs in October to become director of the Central region office in FDA's Office of Regulatory Affairs (1"The Tan Sheet" Dec. 8, 2008, p. 8). Davis has been deputy CIO since November 2007 and will now drive FDA's multi-year information technology modernization program, which will improve import and food protection by enhancing system interoperability

Country-Of-Origin Labeling Would Add Costs But No Consumer Benefit – CRN

Requiring country-of-origin labeling for dietary supplements would be redundant with good manufacturing practices and could raise prices without benefiting consumers, according to the Council for Responsible Nutrition

Annual Registration Fees Proposed For Firms Across FDA’s Regulatory Range

Leading House Democrats plan to expedite hearings on draft legislation to comprehensively strengthen FDA's global safety oversight for food, drug and cosmetic products, with a Health Subcommittee hearing scheduled April 24

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts